Vaccine Antibody Shows Promise for Ovarian Cancer and Melanoma
February 19, 2008 by MedHeadlines
Filed under Cancer, Drugs, Vaccinations, Women's Health
In a recent study, researchers at the Dana-Farber Cancer Institute found that giving patients with advanced melanoma or ovarian cancer that have been immunized with a GVAX vaccine, periodic infusions of anti-CTLA-4 antibodies provides a strong immune response to tumors with less-severe side effects. Read more





